Loosmore S - Search Results

1

Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.

Chong P, Zobrist G, Sia C, Loosmore S, Klein M. Chong P, et al. Among authors: loosmore s. Infect Immun. 1992 Nov;60(11):4640-7. doi: 10.1128/iai.60.11.4640-4647.1992. Infect Immun. 1992. PMID: 1383153 Free PMC article.

2

Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.

Loosmore S, Zealey G, Cockle S, Boux H, Chong P, Yacoob R, Klein M. Loosmore S, et al. Infect Immun. 1993 Jun;61(6):2316-24. doi: 10.1128/iai.61.6.2316-2324.1993. Infect Immun. 1993. PMID: 8500874 Free PMC article.

3

A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.

Yang Yp, Thomas WR, Chong P, Loosmore SM, Klein MH. Yang Yp, et al. Among authors: loosmore sm. Infect Immun. 1998 Jul;66(7):3349-54. doi: 10.1128/IAI.66.7.3349-3354.1998. Infect Immun. 1998. PMID: 9632604 Free PMC article.

4

Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes.

Du RP, Wang Q, Yang YP, Schryvers AB, Chong P, Klein MH, Loosmore SM. Du RP, et al. Among authors: loosmore sm. Infect Immun. 1998 Aug;66(8):3656-65. doi: 10.1128/IAI.66.8.3656-3665.1998. Infect Immun. 1998. PMID: 9673246 Free PMC article.

5

Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Loosmore SM, Zealey GR, Boux HA, Cockle SA, Radika K, Fahim RE, Zobrist GJ, Yacoob RK, Chong PC, Yao FL, et al. Loosmore SM, et al. Infect Immun. 1990 Nov;58(11):3653-62. doi: 10.1128/iai.58.11.3653-3662.1990. Infect Immun. 1990. PMID: 2228237 Free PMC article.

6

Detoxification of pertussis toxin by site-directed mutagenesis: a review of connaught strategy to develop a recombinant pertussis vaccine.

Loosmore S, Cockle S, Zealey G, Boux H, Phillips K, Fahim R, Klein M. Loosmore S, et al. Mol Immunol. 1991 Mar;28(3):235-8. doi: 10.1016/0161-5890(91)90067-t. Mol Immunol. 1991. PMID: 1708104 No abstract available.

7

Development of non-toxigenic vaccine strains of Bordetella pertussis by gene replacement.

Cockle S, Zealey G, Loosmore S, Yacoob R, Fahim R, Yang YP, Jackson G, Boux H, Boux L, Klein M. Cockle S, et al. Among authors: loosmore s. Adv Exp Med Biol. 1991;303:221-5. doi: 10.1007/978-1-4684-6000-1_24. Adv Exp Med Biol. 1991. PMID: 1805567 No abstract available.

8

Detoxification of pertussis toxin by site-directed mutagenesis.

Cockle S, Loosmore S, Radika K, Zealey G, Boux H, Phillips K, Klein M. Cockle S, et al. Among authors: loosmore s. Adv Exp Med Biol. 1989;251:209-14. doi: 10.1007/978-1-4757-2046-4_20. Adv Exp Med Biol. 1989. PMID: 2481961 No abstract available.

9

A unique sequence of the Bordetella pertussis toxin operon.

Loosmore SM, Cunningham JD, Bradley WR, Yao FL, Dekaban GA, Klein MH. Loosmore SM, et al. Nucleic Acids Res. 1989 Oct 25;17(20):8365. doi: 10.1093/nar/17.20.8365. Nucleic Acids Res. 1989. PMID: 2554254 Free PMC article. No abstract available.

10

Hybrid genes over-express pertactin from Bordetella pertussis.

Loosmore SM, Yacoob RK, Zealey GR, Jackson GE, Yang YP, Chong PS, Shortreed JM, Coleman DC, Cunningham JD, Gisonni L, et al. Loosmore SM, et al. Vaccine. 1995 Apr;13(6):571-80. doi: 10.1016/0264-410x(94)00015-f. Vaccine. 1995. PMID: 7483778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters